Peptide-Oligonucleotide Conjugates (POCs) Synthesis

Introduction The use of Peptide-Oligonucleotide Conjugate (POCs) in CNS Drug Delivery represents an advanced bioconjugation strategy designed to transport therapeutic […]

Introduction Maintaining effective Peptide Oligonucleotide Conjugate Storage Stability Handling requires strict control of environmental conditions and adherence to carefully designed

Introduction The optimization of Purification Techniques for Peptide-Oligonucleotide Conjugates depends on the strategic application of orthogonal chromatographic methodologies capable of

Introduction Peptide-oligonucleotide conjugates gain entry into cells mainly through energy-dependent endocytosis or energy-independent direct plasma membrane translocation, with the dominant

Introduction: Anyone comparing an antisense oligonucleotide vs peptide-oligonucleotide conjugate is really asking a structural question: is the therapeutic molecule a

Introduction Endosomal Escape in Peptide Oligonucleotide Conjugates (POC) Therapeutics refers to the physical translocation of synthetic nucleic acid-peptide chimeras from

Introduction The immunogenicity of peptide-oligonucleotide conjugates is a multifaceted biological phenomenon resulting from the synergistic interplay of immunogenic peptide epitopes,

Introduction: Peptide-Oligonucleotide Conjugates in Gene Silencing applications have emerged as one of the most technically sophisticated and clinically promising strategies

Introduction Antisense Oligonucleotide-Peptide Conjugates have emerged as an advanced therapeutic platform designed to address the longstanding pharmacokinetic, biodistribution, and intracellular